PL376791A1 - Stereospecyficzna redukcja sapogen-3-onów - Google Patents
Stereospecyficzna redukcja sapogen-3-onówInfo
- Publication number
- PL376791A1 PL376791A1 PL376791A PL37679103A PL376791A1 PL 376791 A1 PL376791 A1 PL 376791A1 PL 376791 A PL376791 A PL 376791A PL 37679103 A PL37679103 A PL 37679103A PL 376791 A1 PL376791 A1 PL 376791A1
- Authority
- PL
- Poland
- Prior art keywords
- derivative
- steroidal
- steroidal sapogenin
- sapogenin
- reducing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Catalysts (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0225106A GB0225106D0 (en) | 2002-10-28 | 2002-10-28 | Synthesis of 3 hydroxy-5 -steroids |
GB0301505A GB0301505D0 (en) | 2003-01-22 | 2003-01-22 | Stereospecific synthesis of sapogenins |
Publications (2)
Publication Number | Publication Date |
---|---|
PL376791A1 true PL376791A1 (pl) | 2006-01-09 |
PL210114B1 PL210114B1 (pl) | 2011-12-30 |
Family
ID=32178884
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL376791A PL210114B1 (pl) | 2002-10-28 | 2003-04-28 | Sposób stereospecyficznego wytwarzania 3β-hydroksy-5β-H-steroidowych sapogenin |
Country Status (17)
Country | Link |
---|---|
US (1) | US7718792B2 (pl) |
EP (1) | EP1558627B1 (pl) |
JP (1) | JP4607758B2 (pl) |
KR (1) | KR101092150B1 (pl) |
AT (1) | ATE459636T1 (pl) |
AU (1) | AU2003224308A1 (pl) |
BR (1) | BR0315746A (pl) |
CA (1) | CA2503899C (pl) |
DE (1) | DE60331572D1 (pl) |
ES (1) | ES2342274T3 (pl) |
MX (1) | MXPA05004494A (pl) |
PL (1) | PL210114B1 (pl) |
PT (1) | PT1558627E (pl) |
RU (1) | RU2326890C2 (pl) |
SG (1) | SG148860A1 (pl) |
TW (1) | TWI334781B (pl) |
WO (1) | WO2004037845A1 (pl) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0000228D0 (en) * | 2000-01-06 | 2000-03-01 | Phytopharm Plc | Fluoro substituted sapogenins and their use |
KR101130212B1 (ko) * | 2002-03-27 | 2012-04-13 | 파이토팜 피엘씨 | 사포게닌 및 그 유도체의 치료 방법 및 사용법 |
GB0409567D0 (en) | 2004-04-28 | 2004-06-02 | Phytopharm Plc | Chemical compounds |
KR20110018886A (ko) * | 2008-04-30 | 2011-02-24 | 인스티튜트 오브 레디에이션 메디신, 아카데미 오브 밀리터리 메디칼 사이언티시즈 오브 더 피엘에이 | 티모사포닌 bii의 합성 |
CN106810592A (zh) * | 2016-11-29 | 2017-06-09 | 杭州裕美生物科技有限公司 | 一种4‑烯‑3,6‑二酮甾体的合成工艺 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB736818A (en) | 1951-12-28 | 1955-09-14 | Glidden Co | Improvements in or relating to preparation of 3-keto steroids having cis junction of rings a and b |
GB763301A (en) | 1953-09-05 | 1956-12-12 | Farmaceutici Italia | Process for the reduction of í¸-3-keto-steroids to 5-ª -dihydro-steroids |
DE2257132C3 (de) * | 1972-11-18 | 1982-05-13 | Schering Ag, 1000 Berlin Und 4619 Bergkamen | Verfahren zur Reduktion von 3-Ketosteroiden |
RU94046294A (ru) * | 1992-06-26 | 1996-10-10 | Пфайзер Инк. (US) | Стероидные гликозиды для лечения гиперхолестеринэмии |
CA2180148A1 (en) | 1993-12-28 | 1995-07-06 | Michael Paul Deninno | Hypocholesterolemic agents |
EP0782451A1 (en) * | 1994-09-20 | 1997-07-09 | Pfizer Inc. | Combination of a cholesterol absorption inhibitor and a cholesterol synthesis inhibitor |
WO1996038466A1 (en) * | 1995-05-29 | 1996-12-05 | Pfizer Inc. | Steroidal glycosides |
GB9923076D0 (en) * | 1999-09-29 | 1999-12-01 | Phytopharm Plc | Sapogenin derivatives and their use |
ID26989A (id) | 1998-03-26 | 2001-02-22 | Phytopharm Plc | Smilagenin dan anzurogenin-d untuk pengobatan penyakit alzheimer |
GB0000228D0 (en) | 2000-01-06 | 2000-03-01 | Phytopharm Plc | Fluoro substituted sapogenins and their use |
GB0107822D0 (en) | 2001-03-28 | 2001-05-23 | Phytopharm Plc | Sapogenin derivatives their synthesis and use methods based upon their use |
-
2003
- 2003-04-28 WO PCT/GB2003/001780 patent/WO2004037845A1/en active Application Filing
- 2003-04-28 EP EP03720733A patent/EP1558627B1/en not_active Expired - Lifetime
- 2003-04-28 SG SG200703083-6A patent/SG148860A1/en unknown
- 2003-04-28 JP JP2005501542A patent/JP4607758B2/ja not_active Expired - Fee Related
- 2003-04-28 RU RU2005111593/04A patent/RU2326890C2/ru not_active IP Right Cessation
- 2003-04-28 AT AT03720733T patent/ATE459636T1/de active
- 2003-04-28 BR BR0315746-6A patent/BR0315746A/pt not_active IP Right Cessation
- 2003-04-28 KR KR1020057007429A patent/KR101092150B1/ko not_active IP Right Cessation
- 2003-04-28 DE DE60331572T patent/DE60331572D1/de not_active Expired - Lifetime
- 2003-04-28 CA CA2503899A patent/CA2503899C/en not_active Expired - Fee Related
- 2003-04-28 TW TW092109883A patent/TWI334781B/zh not_active IP Right Cessation
- 2003-04-28 ES ES03720733T patent/ES2342274T3/es not_active Expired - Lifetime
- 2003-04-28 US US10/531,086 patent/US7718792B2/en not_active Expired - Fee Related
- 2003-04-28 AU AU2003224308A patent/AU2003224308A1/en not_active Abandoned
- 2003-04-28 MX MXPA05004494A patent/MXPA05004494A/es active IP Right Grant
- 2003-04-28 PT PT03720733T patent/PT1558627E/pt unknown
- 2003-04-28 PL PL376791A patent/PL210114B1/pl not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
JP4607758B2 (ja) | 2011-01-05 |
MXPA05004494A (es) | 2005-07-26 |
US20060041119A1 (en) | 2006-02-23 |
RU2005111593A (ru) | 2006-05-10 |
EP1558627A1 (en) | 2005-08-03 |
RU2326890C2 (ru) | 2008-06-20 |
PT1558627E (pt) | 2010-05-06 |
TWI334781B (en) | 2010-12-21 |
ES2342274T3 (es) | 2010-07-05 |
AU2003224308A1 (en) | 2004-05-13 |
JP2006507360A (ja) | 2006-03-02 |
EP1558627B1 (en) | 2010-03-03 |
WO2004037845A1 (en) | 2004-05-06 |
KR20050090379A (ko) | 2005-09-13 |
SG148860A1 (en) | 2009-01-29 |
BR0315746A (pt) | 2005-09-06 |
CA2503899A1 (en) | 2004-05-06 |
US7718792B2 (en) | 2010-05-18 |
PL210114B1 (pl) | 2011-12-30 |
KR101092150B1 (ko) | 2011-12-12 |
ATE459636T1 (de) | 2010-03-15 |
DE60331572D1 (de) | 2010-04-15 |
CA2503899C (en) | 2011-12-20 |
TW200406215A (en) | 2004-05-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU6172596A (en) | Neuroactive steroids of the androstane and pregnane series | |
TW200603813A (en) | Cyclic progestin regimens and kits | |
NO20070377L (no) | Progesteron reseptor antagonist befruktningshindrende regimer og sett. | |
Lipsett | Gas Chromatography of Steroids in Biological Fluids: Proceedings of theWorkshop on Gas-Liquid Chromatography of Steroids in Biological Fluids | |
DE50308933D1 (de) | Zusammensetzung, enthaltend ein androgenes 11-b-halogensteroid und ein gestagen sowie m nnliches kontrazeptivum auf basis dieser zusammensetzung | |
PL376791A1 (pl) | Stereospecyficzna redukcja sapogen-3-onów | |
RS90504A (en) | C-17 spirolactonization and 6,7 oxidation of steroids | |
Kirchhoff et al. | Differences in the steroid-binding site specificities of rat prostate androgen receptor and epididymal androgen-binding protein (ABP) | |
GB1445945A (en) | Steroids of the d-homo-pregnane series | |
AU2953602A (en) | Process for the production of 16,17-((cyclohexylmethylen)bis(oxy))-11,21-dihydroxy-pregna- 1,4-dien-3,20-dion or its 21-isobutyrat by transketalisation | |
DE69219217D1 (de) | Neue 16-Methyl substituierte Steroidderivate von Pregna-1,4-dien-3,20-dion, ihre Herstellung, ihre Verwendung zur Herstellung von 16-Methylene-substituierte Steroide und neue Zwischenprodukten dafür | |
IE37444B1 (en) | Novel steroids of the d-homo pregnane series | |
YU22903A (sh) | 17alfa-fluoroalkil steroidi, postupak njihove proizvodnje i farmaceutski sastavi koji sadrže ova jedinjenja | |
DE69126622D1 (de) | 2beta,19-methylenamin überbrückte steroide als aromatasehemmer | |
Le Pera et al. | A straightforward chemical synthesis of 17-ketosteroids by cleavage of the C-17-dihydroxy acetone side chain in corticosteroids | |
Kirk et al. | The structure and nomenclature of steroids | |
ATE277071T1 (de) | Durch 11-beta-aryl-17,17-spirothiolan substituierte steroide | |
TH67052A (th) | การสังเคราะห์ซาพอเจนินที่มีความจำเพาะทางสเตริโอเคมี | |
NO20054636L (no) | Fremgangsmate for fremstilling av steroidale karbotiosyrederivater og -intermediater | |
GB892620A (en) | Cyclopentanophenanthrene derivatives | |
PL358032A1 (pl) | Nowe zastosowanie 22R-(11, 16 )-16,17-[butylideno-bis(oksy)]-11,21-dihydroksypregna-1,4-dieno-3,20-dionu | |
GB825210A (en) | Dehydro-compounds of the steroid series and process for their manufacture | |
WETTSTEIN | CIBA-GEIGY Ltd., Basle | |
GB777996A (en) | Steriod compounds and their preparation | |
TW343976B (en) | 17-substituted steroids useful in cancer treatment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RECP | Rectifications of patent specification | ||
LAPS | Decisions on the lapse of the protection rights |
Effective date: 20130428 |